1 Min Read
Oct 4 (Reuters) - Vistagen Therapeutics Inc
* Vistagen Therapeutics appoints Mark A. McPartland vice president of corporate development and investor relations Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.